Table 4.
Device | Sensibility (95% CI) |
Specificity (95% CI) |
Positive predictive value (95% CI) |
Negative predictive value (95% CI) |
---|---|---|---|---|
Spectralis OCTA | 43.3% (39.1–47.5%) |
54.5% (45.2–63.6%) |
81.2% (77.7–84.3%) |
17.4% (15.1–20.1%) |
PlexElite | 27.8% (24.1–31.8%) |
69.4% (60.4–77.5%) |
80.5% (75.4–84.8%) |
17.4% (15.7–19.4%) |
RTVue XR | 24.2% (20.7–28%) |
69.4% (60.4–77.5%) |
78.2% (72.6–83%) |
16.7% (15.1–18.6%) |
AngioPlex | 20.9% (17.6–24.5%) |
71.9% (63–79.7%) |
77.1% (70.9–82.4%) |
16.1% (15.1–18.4%) |
DRI OCT Triton | 24.5% (21.0–28.3%) |
78.5% (70.1–85.4%) |
83.8% (78.2–88.3%) |
18.6% (17.1–20.3%) |
OCTA, optical coherence tomography angiography.